| 1. |
中國侵襲性真菌感染工作組.血液病/惡性腫瘤患者侵襲性真菌病的診斷標準與治療原則(第四次修訂版).中華內科雜志,2013,52(8):704-709.
|
| 2. |
De PB,Walsh TJ,Donnelly JP,et al.Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.Clin Infect Dis,46(12):1813-1821.
|
| 3. |
Walsh TJ,Anaissie EJ,Denning DW,et al.Treatment of aspergillosis:clinical practice guidelines of the Infectious Diseases Society of America.Clin Infect Dis,2008,46(3):327-360.
|
| 4. |
Pappas PG,Kauffman CA,Andes D.Clinical practice guidelines for the management of candidiasis:2009 update by the Infectious Diseases Society of America.Clin Infect Dis,48(5),503-535.
|
| 5. |
Maertens J,Marchetti O,Herbrecht R.European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients:summary of the ECIL 3-2009 Update.Bone Marrow Transplant,2011,46(5):709-718.
|
| 6. |
Lamoth F,Cruciani M,Mengoli C,et al.β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies:a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3).Clin Infect Dis,2012,54(5):633-643.
|
| 7. |
Arendrup MC,Bille J,Dannaoui E,et al.ECIL-3 classical diagnostic procedures for the diagnosis of invasive fungal diseases in patients with leukaemia.Bone Marrow Transplant,2012,47(8):1030-1045.
|
| 8. |
Marchetti O,Lamoth F,Mikulska M,et al.ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients.Bone Marrow Transplant,2012,47(6):846-854.
|
| 9. |
Huang X,Chen H,Han M,et al.Multicenter,randomized,open-label study comparing the efficacy and safety of micafungin versus itraconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplant.Biol Blood Marrow Transplant,2012,18(10):1509-1516.
|
| 10. |
Cheng S,Zhou JF,Zou P,et al.Efficacy and safety of itraconazole as empirical antifungal therapy in febrile neutropenic patients with hematologic malignancies:an open-lable,multicenter,observational trial in a Chinese cohort.Chin Med J (Engl),2011,124(22):3670-3675.
|
| 11. |
Leroux S,Ullmann AJ.Management and diagnostic guidelines for fungal diseases in infectious diseases and clinical microbiology:critical appraisal.Clin Microbiol Infect,2013,19(12):1115-1121.
|
| 12. |
Agrawal S,Jones B,Barnes R,et al.A practical critique of antifungal treatment guidelines for haemato-oncologists.Crit Rev Microbiol,2012,38(3):203-216.
|
| 13. |
Pagano L,Caira M,Offidani M,et al.Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia:feasibility and utility (SEIFEM-2008B study).J Antimicrob Chemother,2010,65(9):2013-2018.
|
